Literature DB >> 8542157

Polyarteritis nodosa with pulmonary vasculitis.

J Nick1, R Tuder, R May, J Fisher.   

Abstract

Although early postmortem series reported pulmonary involvement as a relatively common manifestation of polyarteritis nodosa (PAN), using the modern classification of PAN pulmonary involvement is very uncommon. A 62-yr-old male with well-documented classic PAN was found to have an arteritis of medium-sized muscular pulmonary arteries. The patient subsequently demonstrated a complete response to treatment. Of the few reported cases of PAN with pulmonary manifestations, the majority are autopsy series and the vascular lesion involves the bronchial arteries. There are no case reports of patients with pulmonary involvement of PAN who responded successfully to treatment. This case is the first description of a premortum diagnosis of pulmonary arteritis in PAN in which the patient had a response to treatment.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8542157     DOI: 10.1164/ajrccm.153.1.8542157

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


  3 in total

Review 1.  Pulmonary vasculitis: diagnosis and endovascular therapy.

Authors:  Kiran Batra; Murthy Chamarthy; Rodrigo Caruso Chate; Kirk Jordan; Fernando Uliana Kay
Journal:  Cardiovasc Diagn Ther       Date:  2018-06

2.  An autopsy-proven case of myeloperoxidase-antineutrophil cytoplasmic antibody-positive polyarteritis nodosa with acute renal failure and alveolar hemorrhage.

Authors:  Yusuke Sakaguchi; Takuya Uehata; Hiroaki Kawabata; Kakuya Niihata; Akihiro Shimomura; Akira Suzuki; Tetsuya Kaneko; Tatsuya Shoji; Kohki Shimazu; Hiroaki Fushimi; Yoshiharu Tsubakihara
Journal:  Clin Exp Nephrol       Date:  2010-12-17       Impact factor: 2.801

3.  Pulmonary involvement in primary systemic vasculitides.

Authors:  Jean-Paul Makhzoum; Peter C Grayson; Cristina Ponte; Joanna Robson; Ravi Suppiah; Richard A Watts; Raashid Luqmani; Peter A Merkel; Christian Pagnoux
Journal:  Rheumatology (Oxford)       Date:  2021-12-24       Impact factor: 7.580

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.